Opentrons Labworks Inc.

Opentrons Labworks Inc. is a disruptive life science company leveraging its integrated lab platform to supercharge the pace of innovation in research and healthcare. The parent company to business units Opentrons Robotics and Neochromosome, Opentrons Labworks, Inc. offers a range of groundbreaking solutions. Opentrons Robotics is the industry leader in flexible, user-friendly automation for life science labs. Their open-source ecosystem provides the scientific community with the tools needed to automate experiments, share protocols, and reproduce results. With thousands of academic, biopharma, synthetic biology, and clinical research labs in over 40 countries using Opentrons robots, the company has made a significant impact in the industry. Founded in 2014 and headquartered in the United States, Opentrons Labworks Inc. recently secured a substantial $200.00M Series C investment on 23 September 2021. This investment was led by prominent venture capital firms including Khosla Ventures, SoftBank Vision Fund, and Jacket River. The company's emphasis on open-source technology, coupled with its presence in diverse industries such as Biotechnology, Hardware, and Robotics, positions it as a compelling investment opportunity for venture capitalists seeking exposure to innovative and disruptive startups in the life sciences sector.